Endotoxin levels in donors and recipients during orthotopic liver transplantation

Australian and New Zealand Journal of Surgery

Volumn 67, Issue 4, 1997, Pages 187-191

  Pillay, S P ^a   Wynter, C ^a   Lynch, S ^a   Wall, D ^a   Balderson, G ^a   Strong, R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

endotoxin; liver transplantation

Indexed keywords

ENDOTOXIN;

ADOLESCENT; ADULT; ARTICLE; CANNULATION; CELL MIGRATION; CLINICAL ARTICLE; FEMALE; GRAFT FAILURE; HUMAN; KUPFFER CELL; LIVER TRANSPLANTATION; MALE; PATHOPHYSIOLOGY; PORTAL VEIN BLOOD FLOW; POSTOPERATIVE COMPLICATION; RECIPIENT; TREATMENT OUTCOME;

EID: 0030945346     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1997.tb01938.x     Document Type: Article

References (22)

1. Cuevas P, Fine J. Demonstration of a lethal endotoxemia in experimental occlusion of the superior mesenteric artery. Surg. Gynecol. Obstet. 1971; 133: 81-3.
2. Pillay SP, Moore TD, Lynch SV, Whiting RF, Balderson GA, Strong RW. Endotoxin levels in adult liver donors. Aitst. N.Z. J. Surg. 1994; 64: 615-17.
3. Azoulay D, Astarcioglu I, Lemoine A et al. The effects of donor and recipient endotoxemia on TNF-α production and mortality in the rat model of syngenic orthotopic liver transplantation. Transplantation 1995; 59: 825-9.
4. van Leeuvven PAM, Boermeester MA, Houdijk APJ et al. Clinical significance of translocation. Gut 1994; Suppl. 1: S28-34.
5. Ruiter DJ, van der Meulen J, Brouvver A et al. Uptake by liver cells of endotoxin following intravenous injection. Lab. Invest. 1981; 45: 38-45.
6. Oclay I, Kitaham A, Miller RH et al. Reticuloendothelial dysfunction and endotoxaemia following portal vein occlusion. Surgery 1974; 75: 64-70.
7. Miyata T, Yokoyama I, Todo S, Tzakis A, Selby R, Starzl TE. Endotoxaemia, pulmonary complications and thrombocytopenia in liver transplantation. Lancet 1989; 2: 189-91.
8. Sautner T, Fugger R, Gotzinger P et al. Tumour necrosis factor-α and interleukin-6: Early indicators of bacterial infection after human orthotopic liver transplantation. Eur. J. Surg. 1995; 161: 97-101.
9. Steininger R, Roth E, Fugger R et al. Transhepatic metabolism of TNF-α, IL-6 and endotoxin in the early hepatic reperfusion period after human liver transplantation. Transplantation 1994; 58: 179-82.
10. Lynch S, Kerlin P, Wall D et al. The Queensland liver transplant program: The first 2 years. Med. J. Aust. 1987; 147: 380-5.
11. Roth RI, Levin FC, Levin J. Optimisation of detection of bacterial endotoxin in plasma with the Limiilus test. J. Lab. Clin. Med. 1990; 116: 153-61.
12. Starzl TE, Iwatsuki S, Shaw BW Jr, Gordon RD, Esquivel CO. Immunosuppression and other non-surgical factors in the improved results of liver transplantation. Semin. Liver Dis. 1985; 5: 334-43.
13. Lynch S, Kerlin P, Ong TH et al. Liver transplantation in Australia: The Queensland experience. Transplant. Proc. 1989; 21: 2399-401.
14. Iwanaga S, Morita T, Harada T et al. Chromogenic substrates for horseshoe crab clotting enzyme: Its application for the assay of bacterial endotoxins. Haemostasis 1978; 7: 183-8.
15. Obayashi T. Addition of perchloric acid to blood samples for colorimetric Limiilus test using chromogenic substrate. J. Lab. Clin. Med. 1984; 104: 321-30.
16. United Network for Organ Sharing. Patients waiting for transplants. UNOS Update 1992; 8: 46-8.
17. Yokoyama I, Todo S, Miyata T, Selby R, Tzakis AG, Starzl TE. Endotoxemia and human liver transplantation. Transplant. Proc. 1989; 21: 3833-41.
18. Fugger R, Hamilton G, Steininger R, Mirza D, Schulz F, Muhlbacher F. Intraoperative estimation of endotoxin, TNF-a and IL-6 in orthotopic liver transplantation and their relation to rejection and postoperative infection. Transplantation 1991; 52: 302-6.
19. Hamilton G, Prettenhofer M, Zommer A et al. Intraoperative course and prognostic significance of endotoxin, tumor necrosis factor-alpha and interleukin-6 in liver transplant recipients. Immunobiology 1991; 182: 425-39.
20. Ulevitch RJ, Tobias PS. Recognition of endotoxin by cells leading to transmembrane signalling. Curr. Opin. Immuttol. 1994; 6: 125-30.
21. Read TE, Grunfeld C, Kumwenda Z et al. Triglyceride-rich lipoproteins improve survival when given after endotoxin in rats. Surgery 1995; 117: 62-7.
22. Feingold KR, Funk JL, Moser AH, Shigenaga JK, Rapp JH, Grunfeld C. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect. Immiino. 1995; 63: 2041-6.